Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

Rhea-AI Summary

Avid Bioservices (NASDAQ:CDMO), a biologics contract development and manufacturing organization, will participate in the Credit Suisse 31st Annual Healthcare Conference from November 7-10, 2022. Nick Green, the president and CEO, is scheduled to deliver a presentation on November 9, 2022, from 12:50 to 1:20 p.m. Pacific Time at the Terranea Resort in Rancho Palos Verdes, CA. The company focuses on providing high-quality development and manufacturing services to the biotech and pharmaceutical sectors, boasting nearly 30 years of experience in producing monoclonal antibodies and recombinant proteins.

TUSTIN, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the Credit Suisse 31^st Annual Healthcare Conference. Nick Green, president and chief executive officer of Avid Bioservices, will deliver a corporate presentation at the conference, which will take place November 7-10, 2022, in Rancho Palos Verdes, CA.

Details of the company’s participation are as follows:

• Credit Suisse 31^st Annual Healthcare Conference
  Conference Date: November 7-10, 2022
  Presentation Time/Date: 12:50 - 1:20 p.m. Pacific on Wednesday, November 9, 2022
  Location: Terranea Resort, Rancho Palos Verdes, CA

About Avid Bioservices, Inc.  

Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 29 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

FAQ

When is Avid Bioservices participating in the Credit Suisse 31st Annual Healthcare Conference?

Avid Bioservices will participate in the Credit Suisse 31st Annual Healthcare Conference from November 7-10, 2022.

What time will Avid Bioservices' presentation be at the conference?

Avid Bioservices' presentation will take place on November 9, 2022, from 12:50 to 1:20 p.m. Pacific Time.

Where is the Credit Suisse 31st Annual Healthcare Conference being held?

The conference is being held at the Terranea Resort in Rancho Palos Verdes, California.

Who is the CEO of Avid Bioservices?

Nick Green is the president and CEO of Avid Bioservices.

What services does Avid Bioservices provide?

Avid Bioservices specializes in development and CGMP manufacturing of biologics, including process development and clinical/commercial manufacturing services.